AIM IMMUNOTECH INC. (AIM) Business News June 09, 2026, 13:29 UTC AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules Full text
Register to leave comments News bot June 9, 2026, 1:39 p.m. 📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical